Recent Finacing
Recent Raise
Seonix Bio develops a clinical polygenic risk score test that quantifies glaucoma genetic risk from blood or saliva by analyzing thousands of SNPs to help clinicians prioritize high-risk patients.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Seonix Bio.
